Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis

Immunological Reviews

Volumn 174, Issue , 2000, Pages 238-249

  Yeamon, Stephen J ^a,b   Kirby, John A ^a   Jones, David E J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BINDING PROTEIN; EPITOPE; PYRUVATE DEHYDROGENASE COMPLEX; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL DAMAGE; CHOLANGITIS; CONTROLLED STUDY; EFFECTOR CELL; ENZYME MECHANISM; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0034072905     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0528.2002.00021h.x     Document Type: Review

References (110)

1. 1. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967;60:1257-1261.
2. 2. Neuberger JM. Primary biliary cirrhosis. Lancet 1997;350:875-879.
3. 3. Metcalf JV, Bhopal RS, Gray J, James OFW. Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle-upon-Tyne, England. Int J Epidemiol 1997;26:830-836.
4. 4. James OFW, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the UK? Hepatology 1999;30:390-394.
5. 5. Jones DEJ, James OFW, Bassendine MF. Primary biliary cirrhosis: clinical and associated autoimmune features and natural history. Clin Liver Dis 1998;2:265-282.
6. 6. Prince MI, Jones DEJ. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J (In press).
7. 7. Underbill JA, Donaldson PT, Bray GP, Doherty DG, Portmann BC, Williams R. Genetic analysis in a large series of patients with primary biliary cirrhosis reveals an increased frequency of HLA DRw8 and DQB1 *0402. Hepatology 1992;16:604-607.
8. 8. Gregory W, et al. Primary biliary cirrhosis: contribution of HLA class II allele DR8. Q J Med 1993;86:393-399.
9. 9. Agarwal K, et al. CTLA-4 gene polmorphism confers susceptibility to primary biliary cirrhosis. J Hepatol (In press).
10. 10. Mackay IR. Primary biliary cirrhosis showing a high titre of autoantibody: report of a case study. N Engl J Med 1958;258:185-188.
11. 11. Walker JG, Doniach D, Roitt IM, Sherlock S. Serological test in the diagnosis of primary biliary cirrhosis. Lancet 1965;i:827-831.
12. 12. Berg PA, Klein R, Lindenborn-Fotinos J, Kloppel W. ATPase associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 1982;ii:1423-1426.
13. 13. Berg PA, Klein R, Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol 1986;2:123-131.
14. 14. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding 70 kD mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-3531.
15. 15. Yeaman SJ, Fussey SP, Danner DJ, James OFW, Mutimer DJ, Bassendine MF. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1998;i:1067-1070.
16. 16. Van de Water J, et al. Autoantibodies of primary biliary cirrhosis recognise dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988;141:2321-2324.
17. 17. Jones DEJ, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis - a murine model of primary biliary cirrhosis. Hepatology 1999;30:65-70.
18. 18. Jones DEJ, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Co-sensitisation with self-and homologous foreign-antigen as a mechanism of breakdown of self-tolerance in primary biliary cirrhosis. Gut 1999;44 (Suppl 1):A61.
19. 19. Reed LJ, Yeaman SJ. Pyruvate dehydrogenase. The Enzymes 1987;18:77-95.
20. 20. De Marcucci OGL, Gibb GM, Dick JA, Lindsay JG. Biosynthesis, import and processing of percursor polypeptides of mammalian pyruvate dehydrogenase complex. Biochem J 1988;251:817-823.
21. 21. Reed LJ. Multienzyme complexes. Acc Chem Res 1974;7:40-46.
22. 22. De Marcucci OA, Lindsay JG. Component X. An immunologically distinct polypeptide associated with mammalian pyruvate dehydrogenase multi-enzyme complex. Eur J Biochem 1985;149:641-648.
23. 23. Jilka JM, Rahmatullah M, Kazemi M, Roche TE. Properties of a newly characterised protein of the bovine kidney pyruvate dehydrogenase complex. J Biol Chem 1986;261:1858-1867.
24. 24. Powers-Greenwood SL, Rahmatulla M, Radke GA, Roche TE. Separation of protein X from the dihydrolipoyl transacetylase component of the mammalian pyruvate dehydrogenase complex and function of protein X. J Biol Chem 1989;264:3655-3657.
25. 25. Neagle JC, Lindsay JG. Selective proteolysis of the protein X subunit of the bovine heart pyruvate dehydrogenase complex. Biochem J 1991;278:423-427.
26. 26. Mattevi A, de Kok A, Perham RN. The pyruvate dehydrogenase multienzyme complex. Curr Opin Struct Biol 1992;2:877-887.
27. 27. Reed LJ, Hackert ML. Structure-function relationships in dihydrolipoamide acyltransferases. J Biol Chem 1990;265:8971-8974.
28. 28. Neagle J, De Marcucci O, Dunbar B, Lindsay JG. Component X of mammalian pyruvate dehydrogenase complex: structural and functional relationship to the lipoate acetyltransferase (E2) component. FEBS Lett 1989;253:11-15.
29. 29. Howard MJ, et al. Three dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroemerology 1998;115:139-146
30. 30. Joplin R, Gordon L, Lindsay J, Johnson GD, Strain AJ, Neuberger JM. Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis. Lancet 1992;339:93-94.
31. 31. Joplin R, et al. Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis. Hepatology 1994;19:1375-1380.
32. 32. Van de Water J, et al. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest 1993;91:2653-2664.
33. 33. Joplin R, Wallace LL, Lindsay JG, Palmer JM, Yeaman SJ, Neuberger JM. The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X? Gastroenterology 1997;113:1727-1733.
34. 34. Harada K, Van de Water J, Leung PS, Coppel RL, Nakanuma Y, Gershwin ME. In situ nucleic acid hybridization of pyruvate dehydrogenase complex-E2 in primary biliary cirrhosis: pyruvate dehydrogenase complex-E2 messenger RNA is expressed in hepatocytes but not in biliary epithelium. Hepatology 1997;25:27-32.
35. 35. Harada K, et al. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1-α, BCOADC-E1-α, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Hepatology 1999;30:36-45.
36. 36. Keogh AC, et al. Expression of pyruvate dehydrogenase complex PDC-E2 on biliary epithelial cells induced by incubation with lymph nodes from primary biliary cirrhosis. Hepatology 1999;30:147A.
37. 37. Palmer JM, Bassendine MF, James OFW. Yeaman SJ. Human pyruvate dehydrogenase complex as an autoantigen in primary biliary cirrhosis. Clin Sci 1993;85:289-293.
38. 38. Palmer JM, Jones DEJ, Quinn J, McHugh A, Yeaman SJ. Characterisation of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999;30:21-26.
39. 39. Dubel L, et al. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999;29:1013-1018.
40. 40. Fussey SPM, Bassendine MF, Fittes D, Turner IB, James OFW, Yeaman SJ. The E1α and β subunits of the pyruvate dehydrogenase complex are M2 "d" and M2 "e" autoantigens in primary biliary cirrhosis. Clin Sci 1989;77:365-368.
41. 41. Fussey SPM, et al. Clarification of the identity of the major autoantigen in primary biliary cirrhosis. Clin Sci 1991;80:451-455.
42. 42. Fussey SPM, Guest JR, James OFW, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci USA 1988;85:8654-8658.
43. 43. Surh CD, et al. Reactivity of primary biliary cirrhosis sera with a human fetal liver cDNA clone of branched-chain α-keto acid dehydrogenase dihydrolipoamide acyltransferase, the 52 kDa mitochondrial autoantigen. Hepatology 1989;9:63-68.
44. 44. Mutimer DJ, Fussey SP, Yeaman SJ, Kelly PJ, James OFW, Bassendine MF. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis. Hepatology 1989;10:403-407.
45. 45. Tuaillon N, Andre C, Briand JP, Penner E, Muller S. A lipoyl synthetic octapeptide of dihydrolipoamide acetyltransferase specifically recognised by anti-M2 autoantibodies in primary biliary cirrhosis. J Immunol 1992;148:445-450.
46. 46. Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. J Immunol 1990;144:3367-3374.
47. 47. Fussey SP, Bassendine MF, James OFW, Yeaman SJ. Characterisation of the reactivity of autoantibodies in primary biliary cirrhosis. FEBS Lett 1989;246:49-53.
48. 48. Fussey SPM, Bassendine MF, James OFW, Yeaman SJ. The lipoate-containing domain of PDC-E2 contains the main immunogenic region of the 70 kD M2 autoantigen in primary biliary cirrhosis. Ann N Y Acad Sci 1989;573:444-446.
49. 49. Fussey SPM, Ali ST, Guest JR, James OFW, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterisation of the main immunogenic region. Proc Natl Acad Sci USA 1990;87:3987-3991.
50. 50. Quinn J, Diamond AG, Palmer JM, James OFW, Bassendine MF, Yeaman SJ. Lipoylated and unlipoylated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis: significance of lipoate attachment. Hepatology 1993;18:1384-1391.
51. 51. Harris RA, Bowker Kinley MM, Wu P, Jeng J, Popov KM. Dihydrolipoamide dehydrogenase-binding protein of the human pyruvate dehydrogenase complex. J Biol Chem 1997;272:19746-19751.
52. 52. Leung PS, et al. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995;22:505-513.
53. 53. Moteki S, et al. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 1996;23:436-444.
54. 54. Koike K, Ishbashi H, Koike M. Immunoreactivity of porcine heart dihydrolipoamide acetyl-and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterisation of the autoantigenic region and effects of enzymatic delipoylation and relipoylation. Hepatology 1998;27:1467-1474.
55. 55. Fregeau DR, et al. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain α-ketoacid dehydrogenase complex. J Immunol 1989;142:3815-3818.
56. 56. Fregeau DR, Prindiville T, Coppel RL, Kaplan M, Dickinson RE, Gershwin ME. Inhibition of α-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognising dehydrolipamide succinyltranferase in primary biliary cirrhosis. Hepatology 1990;11:975-980.
57. 57. Rowley MJ, McNeilage JL, Armstrong JM, Mackay IR. Inhibitory autoantibody to a conformational epitope of the pyruvate dehydrogenase complex. Clin Immunol Immunopathol 1991;60:356-370.
58. 58. Teoh KL, Mackay IR, Rowley MJ, Fussey SPM. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis differ for mammalian, yeast and bacterial enzymes: implications for molecular mimicry. Hepatology 1994;19:1029-1033.
59. 59. Neuberger J, Thomson R. PBC and AMA -what is the connection? Hepatology 1999;29:1029-1033.
60. 60. Heseltine L, et al. Primary biliary cirrhosis: quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression. Gastroenterology 1990;99:1786-1792.
61. 61. Kisand KE, et al. Antibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: correlation with histology. APMIS 1998;106:884-892.
62. 62. Krams SM, Surh CD, Coppel RL, Ansari AA, Reubner B, Gershwin ME. Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989;9:411-416.
63. 63. Bassendine MF, et al. Approaches to a murine model of AMA positive non-suppurative destructive cholangitis (NSDC). J Hepatol 1998;28:124.
64. 64. Palmer JM, Jones DEJ, Doshi M, Yeaman SJ, Bassendine MF, Kirby JA. Secretory IgA anti-PDC in primary biliary cirrhosis: a novel mechanism for tissue damage? Hepatology 1998;28:541A.
65. 65. Nishio A, et al. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology 1997;25:1085-1089.
66. 66. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992;89:6901-6905.
67. 67. Malmborg AC, et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun 1998;11:573-580.
68. 68. Van de Water J, et al. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T-cell response of primary biliary cirrhosis. J Immunol 1991;146:89-94.
69. 69. Van de Water J, et al. Heterogeneity of autoreactive T-cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995;181:723-733.
70. 70. Lohr H, Fleischer B, Gerken G, Yeaman SJ, Meyer zum Buschenfelde K-H, Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognise inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol 1993;18:322-327.
71. 71. Jones DEJ, Palmer JM, Yeaman SJ, James OFW, Bassendine MF, Diamond AG. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis. Hepatology 1995;21:995-1002.
72. 72. Jones DEJ, Palmer JM, Yeaman SJ, Bassendine MF, Diamond AG. T-cell responses to native human proteins in primary biliary cirrhosis. Clin Exp Immunol 1997;116:562-568.
73. 73. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-resticted immunodominant T-cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med 1995;181:1835-1845.
74. 74. Shimoda S, et al. Identification and precursor frequency analysis of a common T-cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998;102:1831-1840.
75. 75. Ichiki Y, et al. Analysis of T-cell receptor β of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis. Hepatology 1997;26:728-733.
76. 76. Palmer JM, Diamond AG, Yeaman SJ, Bassendine MF, Jones DEJ. T-cell responses to the putative autoepitope in primary biliary cirrhosis. Clin Exp Immunol 1999;116:133-139.
77. 77. Bjorkland A, Festin R, Mendel-Hartvig I, Nyberg A, Loff L, Totterman T. Blood and liver infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T-cells. Hepatology 1991;13:1106-1111.
78. + T-cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 1995;99:233-239.
79. 79. Harada K, et al. In situ nucleic acid hybridisation of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997;25:791-796.
80. 80. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996;105:254-259.
81. 81. Harada K, Ozaki S, Gershwin ME, Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 1997;26:1399-1405.
82. 82. Jones DEJ, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. The time-course of bile duct lesion development in experimental autoimmune cholangitis (a mouse model of primary biliary cirrhosis). Hepatology 1999;30:318A.
83. 83. Lin RT, Mamula MJ, Hardin JA, Janeway CA. Induction of autoreactive B-cells allows priming of autoreactive T-cells. J Exp Med 1991;173:1433-1439.
84. 84. Mamula MJ, Lin RH, Janeway CA, Hardin JA. Breaking T cell tolerance with foreign and self co-immunogens: a study of B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-795.
85. + T-cell priming in vivo. J Immunol 1999;162:5696-5703.
86. 86. Fuchs E, Matzinger P. B cells drive diversification but not directly. Immunol Today 1993;14:153.
87. 87. Marceau N, Blouin MJ, Germain L, Noel M. Role of different cell types in liver ontogenesis, regeneration and neoplasia. In Vitro Cell Dev Biol 1989;25:336-341.
88. 88. Van Eyken P, Sciot R, Desmet VJ. Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest 1988;59:52-59.
89. 89. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations of the theme 'ductal plate malformation'. Hepatology 1992;16:1069-1083.
90. 90. Leon MP, Bassendine MF, Thick M, Gibbs P, Burt AD, Kirby JA. Hepatic allograft rejection: regulation of the immunogenicity of human intrahepatic biliary epithelial cells. J Liver Transpl Surg 1996;2:37-45.
91. 91. Joplin R. Isolation and culture of human biliary epithelial cells. Gut 1994;35:875-878.
92. 92. Hreha G, et al. Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity. Hepatology 1999;30:358-371.
93. 93. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 1995;22:591-595.
94. + T cells. Hepatology 1996;24:561-567.
95. 95. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221-227.
96. 96. Korlipara LVP, et al. Development of a flow cytometric assay to quantify lymphocyte adhesion to cytokine-stimulated human endothelial and biliary epithelial cells. J Immunol Methods 1996;191:121-130.
97. 97. Lenschow DJ, Walanus TL, Bluestone JA. CD28/B7 system of T-cell costimulation. Annu Rev Immunol 1996;14:233-258.
98. 98. Kirby JA, Rajasekar MR, Lin Y, Proud G, Taylor RMR. Interaction between T lymphocytes and kidney epithelial cells during renal allograft rejection. Kidney Int 1993;43(Suppl 39):124-128.
99. 99. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-1356.
100. 100. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994;264:1587-1589.
101. 101. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: Study of the adhesive interaction with lymphocytes. Gastroenterology 1997;112:968-977.
102. 102. Kilshaw PJ. α E β 7. J Clin Pathol Mol Pathol 1999;52:203-207.
103. + cytolytic T lymphocytes. Transplantation 1999;67:1418-1425.
104. + T cells around acinar epithelial cells with apoptosis in patients with Sjögren's syndrome. J Immunol 1999;163:2226-2235.
105. 105. Zhang C, Ao Z, Scholossman SF. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J Immunol 1996;157:3980-3987.
106. 106. Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999;190:815-825.
107. 107. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on cultured keratinocytes. J Exp Med 1994;179:1317-1330.
108. 108. Inaba K, et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatability complex class II products of dendritic cells. J Exp Med 1998;188:1163-2173.
109. 109. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 1998;392:86-89.
110. 110. Lu L, et al. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994;179:1823-1834.